LYNN BAXTER

Head of North America

Lynn Baxter became our Head of North America on 1 February 2019, joining ViiV Healthcare from GSK where she most recently led the Global Vaccines Commercial business. She has a proven track record of delivering consistent robust performance and impact while in varied roles, geographies, and therapeutic areas.

Prior to this, Lynn held various positions in GSK. She was General Manager of GSK Philippines where she was accountable for running all aspects of the local Pharma operating company. Before moving to the Philippines, she was Head of Commercial Operations for Emerging Markets, based at GSK Global Headquarters in London. Covering more than 100 diverse countries, Lynn was responsible for driving pharmaceuticals business performance, delivering business transformation, and significant global corporate change initiatives, as well as building commercial capabilities.

Previously, Lynn was Global Head of Hepatitis and Travel Vaccines, GSK Global Vaccines based in Belgium where she led a vertical end-to-end cross-functional matrix organisation, encompassing R&D, manufacturing, and commercialisation. Earlier on, she was based in Shanghai as Growth Strategy Director for Vaccines. She joined GSK in 2009 as a Marketing Director for Europe and Emerging Markets.

Before joining GSK, Lynn was with Roche Pharmaceuticals in various positions, including HIV Franchise Leader and Global Marketing Excellence Lead. Her earlier career was spent at Merck Sharp & Dohme (MSD) in the UK, in a variety of sales and marketing roles of increasing seniority.

Our Executive Team

Harmony Garges, Chief Medical Officer at ViiV Healthcare
Dr Harmony Garges

Chief Medical Officer

Read more
Kimberly Smith, Head of Research and Development, ViiV Healthcare
Dr Kimberly Smith

Head of Research and Development

Read more
Lynn Baxter, Head of North America, ViiV Healthcare
Lynn Baxter

Head of North America

Read more
Neil Wilkinson, Chief Financial Officer
Neil Wilkinson

Chief Financial Officer

Read more
Cheryl MacDiarmid, Head of Global Commercial Strategy, ViiV Healthcare
Cheryl MacDiarmid

Head of Global Commercial Strategy

Read more
Andrew Stewart, General Counsel and Chief Compliance Officer, ViiV Healthcare
Andrew Stewart

General Counsel and Chief Compliance Officer

Read more
Stephen Rea, Head of External Affairs and Communications ViiV Healthcare
Stephen Rea

Head of External Affairs and Communications

Read more
Lauren Carey, Head of International
Lauren Carey

Head of International

Read more

YOU MAY ALSO BE INTERESTED IN

We are ViiV Healthcare: 100% dedicated to HIV medicines and research and focused on people living with HIV and AIDS.

Together we are engaged in the HIV response throughout the world, supported by a team of over 1,100 dedicated ViiV Healthcare staff working across the globe.

Discover more about who we are, the work we do and what we're doing to advance HIV science, support the delivery of HIV treatment and care; and work with partners to address the stigma and discrimination faced by people living with HIV.

NP-GBL-HVX-COCO-220025

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.